Jennifer Holter‐Chakrabarty

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk et al. · Journal of Clinical Oncology · 2017 · 318 citations · Full text

Life Sciences, Hematology, Immunology +16

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Marcela V. Maus, S. Alexander, Michael R. Bishop et al. · Journal for ImmunoTherapy of Cancer · 2020 · 269 citations · Full text

Life Sciences, Immunology, Oncology +17

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

Jane A. O’Halloran, Emily R. Ko, Kevin J. Anstrom et al. · JAMA · 2023 · 67 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +11

Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia

Juliet N. Barker, Mingwei Fei, Chatchada Karanes et al. · British Journal of Haematology · 2014 · 43 citations · Full text

Medicine, Hematology, Stem Cell Transplantation +16

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma

Narendranath Epperla, Ambuj Kumar, Syed A. Abutalib et al. · Transplantation and Cellular Therapy · 2023 · 38 citations · Full text

Medicine, Hematology, Oncology +14